Results 161 to 170 of about 19,008,149 (295)

System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma. [PDF]

PLoS One, 2023
Huang R, Guo L, Chen C, Xiang Y, Li G, Zheng J, Wu Y, Yuan X, Zhou J, Gao W, Xiang S.   +10 more
europepmc   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Nationwide Trends in Arthroscopic Knee Surgery and ACL Reconstruction in Romania, 2017-2023: Insights from a Seven-Year Health System Analysis. [PDF]

Life (Basel)
Tolan GA, Precup CV, Uivaraseanu B, Tit DM, Bungau GS, Radu AF, Furau CG.   +6 more
europepmc   +1 more source

Dynamical system analysis of interacting dark energy in LRS Bianchi type I cosmology. [PDF]

Sci Rep, 2023
Rathore S, Singh SS.
europepmc   +1 more source

Systems Analysis [PDF]

Nature, 1972
openaire   +1 more source

BIG DATA ANALYSIS VIA PAYMENT SYSTEM [PDF]

, 2013
Reshetilova, T., Shpynov, A., Shvets, O.
core   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

The Evolution and Challenges of Family Medicine in Kyrgyzstan: A Health System Analysis. [PDF]

Fam Med
Asanbek Kyzy A, Sulaimanova G, Kalmatov R, Mamyrova K, Abdyrasulov K, Fonken P, Bardella IJ.   +6 more
europepmc   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Combined warming index energy system analysis framework for methane leakage rate and carbon capture rate uncertainty. [PDF]

MethodsX
Davids D, Grant N, Mittal S, Hawkes A, Oluleye G.   +4 more
europepmc   +1 more source